Floatz logo

ETONOGESTREL

Drug Interactions

University of Sao PauloSmall moleculePhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Drug Interactions cohort.

Asset / SponsorPhaseRating
Deupirfenidone
PureTech
Phase 1CC
Rosuvastatin
Bayer
Phase 1CC

Same molecule, other indications

ETONOGESTREL is also rated in:

ContraceptionDormant
BB
Indicative ·
65 / 100
View asset →
Adverse Effect of Oral Contraceptives, SequelaDormant
BB
Indicative ·
65 / 100
View asset →
polycystic ovary syndromeDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →